IR-Med (IRME) Free Cash Flow Growth (1y) (2021 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.73% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -109.40% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 133.09% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 363.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 108.16% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 29.12% |
| 10 | IR-Med | - | - | - | 80.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 80.91% |
| Mar 31, 2025 | 69.27% |
| Dec 31, 2024 | 65.43% |
| Sep 30, 2024 | 51.29% |
| Jun 30, 2024 | 51.50% |
| Mar 31, 2024 | 60.22% |
| Dec 31, 2023 | 3.33% |
| Sep 30, 2023 | -17.88% |
| Jun 30, 2023 | 35.60% |
| Mar 31, 2023 | -17.65% |
| Dec 31, 2022 | 6.02% |
| Sep 30, 2022 | -2.08% |
| Jun 30, 2022 | -134.91% |
| Mar 31, 2022 | -52.69% |
| Dec 31, 2021 | -575.61% |